Ana Gabriela Henriques, PhD

Cell Biology University of Aveiro, Aveiro, Aveiro, Portugal 
Alzheimer's disease
"Ana Henriques"

Mean distance: 15.7 (cluster 32)
Cross-listing: Alzheimer's Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rosa IM, Henriques AG, Wiltfang J, et al. (2017) Putative Dementia Cases Fluctuate as a Function of Mini-Mental State Examination Cut-Off Points. Journal of Alzheimer's Disease : Jad
Henriques AG, Müller T, Oliveira JM, et al. (2016) Altered protein phosphorylation as a resource for potential AD biomarkers. Scientific Reports. 6: 30319
Oliveira JM, Henriques AG, Martins F, et al. (2015) Amyloid-β Modulates Both AβPP and Tau Phosphorylation. Journal of Alzheimer's Disease : Jad. 45: 495-507
Henriques AG, Oliveira JM, Carvalho LP, et al. (2014) Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer's Disease. Molecular Neurobiology
Domingues SC, Konietzko U, Henriques AG, et al. (2014) RanBP9 modulates AICD localization and transcriptional activity via direct interaction with Tip60. Journal of Alzheimer's Disease : Jad. 42: 1415-33
Henriques AG, Oliveira JM, Gomes B, et al. (2014) Complexing Aβ prevents the cellular anomalies induced by the Peptide alone. Journal of Molecular Neuroscience : Mn. 53: 661-8
Baptista FI, Henriques AG, Silva AM, et al. (2014) Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease. Acs Chemical Neuroscience. 5: 83-92
Henriques AG, Vieira SI, Silva OABDCE. (2012) Abeta induces abnormal cytoskeletal dynamics which are reversible upon peptide removal Microscopy and Microanalysis. 18: 23-24
Domingues SC, Henriques AG, Fardilha M, et al. (2011) Identification and characterization of a neuronal enriched novel transcript encoding the previously described p60Fe65 isoform. Journal of Neurochemistry. 119: 1086-98
da Cruz e Silva OA, Henriques AG, Domingues SC, et al. (2010) Wnt signalling is a relevant pathway contributing to amyloid beta- peptide-mediated neuropathology in Alzheimer's disease. Cns & Neurological Disorders Drug Targets. 9: 720-6
See more...